Search Results - "Ritter, David M"

Refine Results
  1. 1

    Prevalence of thoracoabdominal imaging findings in tuberous sclerosis complex by Ritter, David M, Fessler, Bailey K, Ebrahimi-Fakhari, Daniel, Wei, Jun, Franz, David N, Krueger, Darcy A, Trout, Andrew T, Towbin, Alexander J

    Published in Orphanet journal of rare diseases (15-03-2022)
    “…Tuberous sclerosis complex (TSC) results in neurodevelopmental phenotypes, benign tumors, and cysts throughout the body. Recent studies show numerous rare…”
    Get full text
    Journal Article
  2. 2

    A-Type KV Channels in Dorsal Root Ganglion Neurons: Diversity, Function, and Dysfunction by Zemel, Benjamin M., Ritter, David M., Covarrubias, Manuel, Muqeem, Tanziyah

    Published in Frontiers in molecular neuroscience (06-08-2018)
    “…A-type voltage-gated potassium (Kv) channels are major regulators of neuronal excitability that have been mainly characterized in the central nervous system…”
    Get full text
    Journal Article
  3. 3

    Modeling-independent elucidation of inactivation pathways in recombinant and native A-type Kv channels by Fineberg, Jeffrey D, Ritter, David M, Covarrubias, Manuel

    Published in The Journal of general physiology (01-11-2012)
    “…A-type voltage-gated K(+) (Kv) channels self-regulate their activity by inactivating directly from the open state (open-state inactivation [OSI]) or by…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    A-Type K V Channels in Dorsal Root Ganglion Neurons: Diversity, Function, and Dysfunction by Zemel, Benjamin M, Ritter, David M, Covarrubias, Manuel, Muqeem, Tanziyah

    Published in Frontiers in molecular neuroscience (06-08-2018)
    “…A-type voltage-gated potassium (Kv) channels are major regulators of neuronal excitability that have been mainly characterized in the central nervous system…”
    Get full text
    Journal Article
  7. 7

    Mammalian Target of Rapamycin Inhibitor Levels Decrease Under Cenobamate Treatment by Becker, Lena-Luise, Agricola, Karen, Ritter, David M., Krueger, Darcy A., Franz, David Neal

    Published in Pediatric neurology (01-12-2024)
    “…Everolimus therapy has been approved in Tuberous Sclerosis Complex (TSC), for drug-resistant epilepsy as adjunctive therapy. A novel anti-seizure medication is…”
    Get full text
    Journal Article
  8. 8

    Impact of Race in Missed Appointments in Pediatric Neurology Resident Clinic at a Large Tertiary Medical Center by Albor, Lauren C., Horn, Paul S., Venkatesan, Charu, Ritter, David M.

    Published in Journal of child neurology (01-06-2024)
    “…Missed medical appointments are a common problem across specialties. The discontinuity of care leads to unplanned health care utilization, increased costs, and…”
    Get full text
    Journal Article
  9. 9

    In Silico Predictions of KCNQ Variant Pathogenicity in Epilepsy by Ritter, David M., Horn, Paul S., Holland, Katherine D.

    Published in Pediatric neurology (01-05-2021)
    “…Variants in KCNQ2 and KCNQ3 may cause benign neonatal familial seizures and early infantile epileptic encephalopathy. Previous reports suggest that in silico…”
    Get full text
    Journal Article
  10. 10

    Dysregulation of Kv3.4 channels in dorsal root ganglia following spinal cord injury by Ritter, David M, Zemel, Benjamin M, Hala, Tamara J, O'Leary, Michael E, Lepore, Angelo C, Covarrubias, Manuel

    Published in The Journal of neuroscience (21-01-2015)
    “…Spinal cord injury (SCI) patients develop chronic pain involving poorly understood central and peripheral mechanisms. Because dysregulation of the…”
    Get full text
    Journal Article
  11. 11

    Diabetes in Individuals With Tuberous Sclerosis Complex Treated With mTOR Inhibitors by Agricola, Karen, Stires, Gabrielle, Krueger, Darcy A., Capal, Jamie K., Franz, David N., Ritter, David M.

    Published in Pediatric neurology (01-07-2021)
    “…Tuberous sclerosis complex (TSC) is a genetic disorder that is manifested in multiple body systems. A mammalian target of rapamycin (mTOR) inhibitor (mTORi),…”
    Get full text
    Journal Article
  12. 12

    Modulation of Kv3.4 channel N‐type inactivation by protein kinase C shapes the action potential in dorsal root ganglion neurons by Ritter, David M., Ho, Cojen, O’Leary, Michael E., Covarrubias, Manuel

    Published in The Journal of physiology (01-01-2012)
    “…Non‐technical summary  The orchestrated activity of an ensemble of voltage‐gated ion channels determines the initiation, shape and duration of the action…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Kv3.4 channel function and dysfunction in nociceptors by Ritter, David M, Zemel, Benjamin M, Lepore, Angelo C, Covarrubias, Manuel

    Published in Channels (Austin, Tex.) (04-07-2015)
    “…Recently, we reported the isolation of the Kv3.4 current in dorsal root ganglion (DRG) neurons and described dysregulation of this current in a spinal cord…”
    Get full text
    Journal Article
  17. 17

    Kv3.4 channel function and modulation in nociceptors: Novel insights into the pathophysiology of neuropathic pain by Ritter, David M

    Published 01-01-2013
    “…Chronic neuropathic pain affects millions of people worldwide; however, there remain few effective treatments for this condition. This is especially true in…”
    Get full text
    Dissertation
  18. 18
  19. 19
  20. 20